Day: June 3, 2021

WCPGHAN 2021: Fish oil taken during pregnancy boosts problem-solving and concentration in children, new data reveals

GENEVA, June 4, 2021 /PRNewswire/ — Children born to mothers who took fish oil in their pregnancies have been shown to have faster problem-solving skills and better attention focus at age 10, according to findings from an EU funded study presented today at the 6th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition. This is the first […]

Huawei and Temenos Announce Technology Partnership Agreement

Temenos Becomes First Core Banking Software Provider Certified with Huawei infrastructure and Huawei Public Cloud Temenos and Huawei will jointly go-to-market with leading-edge financial services offerings in the cloud to drive scalability, operational efficiency, time-to-market, and innovation Temenos cements its leadership in the cloud delivering its software across all major public cloud providers GENEVA, Switzerland […]

Huawei Launches Lossless Ethernet Storage Network Solution NoF+ to Spark Digital Finance Innovation

SHANGHAI, June 4, 2021 /PRNewswire/ — At the Huawei Intelligent Finance Summit 2021, Huawei launched the lossless Ethernet storage networking solution, NoF+. The solution implements end-to-end data acceleration in storage scenarios by leveraging OceanStor Dorado all-flash storage systems and CloudEngine data center storage network switches. It fully unlocks the potential of all-flash performance, and injects […]

Huawei Launches the Financial Cloud-Network Solution to Lay the Cornerstone of Connectivity for Intelligent Finance

SHANGHAI, June 4, 2021 /PRNewswire/ — At the Huawei Intelligent Finance Summit 2021, Huawei launched its all-new Financial Cloud-Network Solution designed to enable financial institutions to build a “stable and high-speed” bimodal architecture. The end goal is to accelerate service innovation, deliver secure and reliable financial services, and lay the cornerstone of connectivity for intelligent finance. […]

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone). 2. PaTHway China Trial is designed to assess the potential of […]

Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange

TUSTIN, Calif., June 3, 2021 /PRNewswire/ — On Wednesday, May 26, 2021, Sofwave™ Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE). Sofwave’s™, rapid market adoption enabled the listing on the Tel Aviv Stock Exchange.  The company managed to raise $50 million at a pre-money valuation of ~$200 million. The IPO was […]

Back To Top